Azacitidine in 302 patients with WHO-defined acute myeloid leukemia: results from the Austrian Azacitidine Registry of the AGMT-Study Group.

Lisa Pleyer; Sonja Burgstaller; Michael Girschikofsky; Werner Linkesch; Reinhard Stauder; Michael Pfeilstocker; Martin Schreder; Christoph Tinchon; Thamer Sliwa; Alois Lang; Wolfgang R Sperr; Peter Krippl; Dietmar Geissler; Daniela Voskova; Konstantin Schlick; Josef Thaler; Sigrid Machherndl-Spandl; Georg Theiler; Otto Eckmüllner; Richard Greil

doi:10.1007/s00277-014-2126-9

Azacitidine in 302 patients with WHO-defined acute myeloid leukemia: results from the Austrian Azacitidine Registry of the AGMT-Study Group.

Lisa Pleyer^* (First author), Sonja Burgstaller, Michael Girschikofsky, Werner Linkesch, Reinhard Stauder, Michael Pfeilstocker, Martin Schreder, Christoph Tinchon, Thamer Sliwa, Alois Lang, Wolfgang R Sperr, Peter Krippl, Dietmar Geissler, Daniela Voskova, Konstantin Schlick (Co-author), Josef Thaler, Sigrid Machherndl-Spandl, Georg Theiler, Otto Eckmüllner, Richard Greil (Last author)

^*Corresponding author for this work

Department of Internal Medicine III - Division of Hematology, Medical Oncology, Hemostaseology, Rheumatology, Infectiology and Oncologic Center

Research output: Contribution to journal › Original Article › peer-review

83 Citations (Web of Science)

Original language	English
Pages (from-to)	1825-1838
Journal	ANNALS OF HEMATOLOGY
Volume	93
Issue number	11
DOIs	https://doi.org/10.1007/s00277-014-2126-9
Publication status	Published - 2014

Keywords

INTERNATIONAL WORKING GROUP
CONVENTIONAL CARE REGIMENS
MONOSOMAL KARYOTYPE
MYELODYSPLASTIC SYNDROMES
RESPONSE CRITERIA
SURVIVAL
PROGNOSIS
TRIALS
ADULT
AML

Access to Document

10.1007/s00277-014-2126-9

Cite this

Pleyer, L., Burgstaller, S., Girschikofsky, M., Linkesch, W., Stauder, R., Pfeilstocker, M., Schreder, M., Tinchon, C., Sliwa, T., Lang, A., Sperr, W. R., Krippl, P., Geissler, D., Voskova, D., Schlick, K., Thaler, J., Machherndl-Spandl, S., Theiler, G., Eckmüllner, O., & Greil, R. (2014). Azacitidine in 302 patients with WHO-defined acute myeloid leukemia: results from the Austrian Azacitidine Registry of the AGMT-Study Group. ANNALS OF HEMATOLOGY , 93(11), 1825-1838. https://doi.org/10.1007/s00277-014-2126-9

Pleyer, Lisa ; Burgstaller, Sonja ; Girschikofsky, Michael et al. / Azacitidine in 302 patients with WHO-defined acute myeloid leukemia: results from the Austrian Azacitidine Registry of the AGMT-Study Group. In: ANNALS OF HEMATOLOGY 2014 ; Vol. 93, No. 11. pp. 1825-1838.

@article{26d0e0eaa2a546ecb79549fdc4a60459,

title = "Azacitidine in 302 patients with WHO-defined acute myeloid leukemia: results from the Austrian Azacitidine Registry of the AGMT-Study Group.",

keywords = "INTERNATIONAL WORKING GROUP, CONVENTIONAL CARE REGIMENS, MONOSOMAL KARYOTYPE, MYELODYSPLASTIC SYNDROMES, RESPONSE CRITERIA, SURVIVAL, PROGNOSIS, TRIALS, ADULT, AML",

author = "Lisa Pleyer and Sonja Burgstaller and Michael Girschikofsky and Werner Linkesch and Reinhard Stauder and Michael Pfeilstocker and Martin Schreder and Christoph Tinchon and Thamer Sliwa and Alois Lang and Sperr, {Wolfgang R} and Peter Krippl and Dietmar Geissler and Daniela Voskova and Konstantin Schlick and Josef Thaler and Sigrid Machherndl-Spandl and Georg Theiler and Otto Eckm{\"u}llner and Richard Greil",

note = "Paracelsus Med Univ Hosp Salzburg, Med Dept Hematol & Med Oncol 3, Lab Immunol & Mol Canc Res, Ctr Oncol, A-5020 Salzburg, Austria; Salzburg Canc Res Inst, Ctr Clin Canc & Immunol Trials, A-5020 Salzburg, Austria; Hosp Wels Grieskirchen, Dept Internal Med 4, Wels, Austria; Elisabethinen Hosp, Med Dept Hematol Stem Cell Transplantat Hemostats, Linz, Austria; Med Univ, Dept Hematol, Graz, Austria; Med Univ Innsbruck, A-6020 Innsbruck, Austria; Hanusch Hosp, Dept Med 3, Vienna, Austria; Wilhelminenspital Stadt Wien, Dept Internal Med 1, Ctr Oncol & Hematol, Vienna, Austria; LKH Leoben Eisenerz, Dept Hematol & Oncol, Leoben, Austria; 5th Med Dept Oncol & Palliat Med, Vienna, Austria; Hosp Feldkirch, Feldkirch, Austria; Med Univ Vienna, Div Hematol & Hemostaseol, Dept Internal Med 1, Vienna, Austria; LKH Fuerstenfeld, Dept Internal Med, Fuerstenfeld, Austria; Klinikum Klagenfurt Wortersee, Dept Internal Med, Intens Care Unit, Portschach Am Worthersee, Austria; Klinikum Klagenfurt Wortersee, Portschach Am Worthersee, Austria; Gen Hosp Linz GesmbH, Ctr Hematol & Med Oncol, Linz, Austria; Univ Bodenkultur Wien, Inst Waldwachstumsforsch, A-1180 Vienna, Austria",

year = "2014",

doi = "10.1007/s00277-014-2126-9",

language = "English",

volume = "93",

pages = "1825--1838",

journal = "ANNALS OF HEMATOLOGY ",

issn = "0939-5555",

number = "11",

}

Pleyer, L, Burgstaller, S, Girschikofsky, M, Linkesch, W, Stauder, R, Pfeilstocker, M, Schreder, M, Tinchon, C, Sliwa, T, Lang, A, Sperr, WR, Krippl, P, Geissler, D, Voskova, D, Schlick, K, Thaler, J, Machherndl-Spandl, S, Theiler, G, Eckmüllner, O & Greil, R 2014, 'Azacitidine in 302 patients with WHO-defined acute myeloid leukemia: results from the Austrian Azacitidine Registry of the AGMT-Study Group.', ANNALS OF HEMATOLOGY , vol. 93, no. 11, pp. 1825-1838. https://doi.org/10.1007/s00277-014-2126-9

Azacitidine in 302 patients with WHO-defined acute myeloid leukemia: results from the Austrian Azacitidine Registry of the AGMT-Study Group. / Pleyer, Lisa (First author); Burgstaller, Sonja; Girschikofsky, Michael et al.
In: ANNALS OF HEMATOLOGY , Vol. 93, No. 11, 2014, p. 1825-1838.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - Azacitidine in 302 patients with WHO-defined acute myeloid leukemia: results from the Austrian Azacitidine Registry of the AGMT-Study Group.

AU - Pleyer, Lisa

AU - Burgstaller, Sonja

AU - Girschikofsky, Michael

AU - Linkesch, Werner

AU - Stauder, Reinhard

AU - Pfeilstocker, Michael

AU - Schreder, Martin

AU - Tinchon, Christoph

AU - Sliwa, Thamer

AU - Lang, Alois

AU - Sperr, Wolfgang R

AU - Krippl, Peter

AU - Geissler, Dietmar

AU - Voskova, Daniela

AU - Schlick, Konstantin

AU - Thaler, Josef

AU - Machherndl-Spandl, Sigrid

AU - Theiler, Georg

AU - Eckmüllner, Otto

AU - Greil, Richard

N1 - Paracelsus Med Univ Hosp Salzburg, Med Dept Hematol & Med Oncol 3, Lab Immunol & Mol Canc Res, Ctr Oncol, A-5020 Salzburg, Austria; Salzburg Canc Res Inst, Ctr Clin Canc & Immunol Trials, A-5020 Salzburg, Austria; Hosp Wels Grieskirchen, Dept Internal Med 4, Wels, Austria; Elisabethinen Hosp, Med Dept Hematol Stem Cell Transplantat Hemostats, Linz, Austria; Med Univ, Dept Hematol, Graz, Austria; Med Univ Innsbruck, A-6020 Innsbruck, Austria; Hanusch Hosp, Dept Med 3, Vienna, Austria; Wilhelminenspital Stadt Wien, Dept Internal Med 1, Ctr Oncol & Hematol, Vienna, Austria; LKH Leoben Eisenerz, Dept Hematol & Oncol, Leoben, Austria; 5th Med Dept Oncol & Palliat Med, Vienna, Austria; Hosp Feldkirch, Feldkirch, Austria; Med Univ Vienna, Div Hematol & Hemostaseol, Dept Internal Med 1, Vienna, Austria; LKH Fuerstenfeld, Dept Internal Med, Fuerstenfeld, Austria; Klinikum Klagenfurt Wortersee, Dept Internal Med, Intens Care Unit, Portschach Am Worthersee, Austria; Klinikum Klagenfurt Wortersee, Portschach Am Worthersee, Austria; Gen Hosp Linz GesmbH, Ctr Hematol & Med Oncol, Linz, Austria; Univ Bodenkultur Wien, Inst Waldwachstumsforsch, A-1180 Vienna, Austria

PY - 2014

Y1 - 2014

KW - INTERNATIONAL WORKING GROUP

KW - CONVENTIONAL CARE REGIMENS

KW - MONOSOMAL KARYOTYPE

KW - MYELODYSPLASTIC SYNDROMES

KW - RESPONSE CRITERIA

KW - SURVIVAL

KW - PROGNOSIS

KW - TRIALS

KW - ADULT

KW - AML

U2 - 10.1007/s00277-014-2126-9

DO - 10.1007/s00277-014-2126-9

M3 - Original Article

C2 - 24951123

SN - 0939-5555

VL - 93

SP - 1825

EP - 1838

JO - ANNALS OF HEMATOLOGY

JF - ANNALS OF HEMATOLOGY

IS - 11

ER -

Pleyer L, Burgstaller S, Girschikofsky M, Linkesch W, Stauder R, Pfeilstocker M et al. Azacitidine in 302 patients with WHO-defined acute myeloid leukemia: results from the Austrian Azacitidine Registry of the AGMT-Study Group. ANNALS OF HEMATOLOGY . 2014;93(11):1825-1838. doi: 10.1007/s00277-014-2126-9